ImmunoTronics is an early-stage MedTech venture. The startup aims to develop electrochemical/electronic biosensors for Point-of-Care diagnostics. ImmunoTronics is working on a solution for rapid sepsis diagnostics, utilising immunoFET technology, an innovative combination of biomarkers, and predictive models based on artificial intelligence algorithms. Currently, the founding team is seeking external support to accelerate the development of the solution and internationalise the venture beyond the current research grants. Ultimately, in addition to developing biosensor technology for Point-of-Care diagnostics, ImmunoTronics aims to leverage its expertise to foster collaborations with scientific and industrial partners as a contract research organisation.